{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:32:28Z","timestamp":1740119548743,"version":"3.37.3"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"am","delay-in-days":236,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","americanjournalofsurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.amjsurg.2024.115820","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T01:26:56Z","timestamp":1720229216000},"page":"115820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9275-6267","authenticated-orcid":false,"given":"Alexander C.","family":"Schulick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter B.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador Rodriguez","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie G.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barish H.","family":"Edil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Schulick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor L.","family":"Nydam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin D.","family":"McCarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Del Chiaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gleisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"25","key":"10.1016\/j.amjsurg.2024.115820_bib2","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5009\/gnl.2014.8.1.102","article-title":"Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection?","volume":"8","author":"La Torre","year":"2014","journal-title":"Gut Liver"},{"key":"10.1016\/j.amjsurg.2024.115820_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1477-7819-12-360","article-title":"Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma","volume":"12","author":"Kimura","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115820_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1245\/s10434-011-2020-9","article-title":"Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer","volume":"19","author":"Hata","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2024.115820_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/SLA.0000000000003301","article-title":"Surgery improves survival after neoadjuvant therapy for borderline and locally advanced pancreatic cancer: a single institution experience","volume":"273","author":"Rangelova","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2024.115820_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SLA.0000000000002600","article-title":"Predictors of resectability and survival in patients with borderline and locally advanced pancreatic cancer who underwent neoadjuvant treatment with FOLFIRINOX","volume":"269","author":"Michelakos","year":"2019","journal-title":"Annals of surgery"},{"issue":"8","key":"10.1016\/j.amjsurg.2024.115820_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/bjs.10870","article-title":"Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer","volume":"105","author":"Versteijne","year":"2018","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115820_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.hpb.2018.07.017","article-title":"Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer","volume":"21","author":"Del Chiaro","year":"2019","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115820_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jamcollsurg.2018.05.001","article-title":"Indications and perioperative outcomes for pancreatectomy with arterial resection","volume":"227","author":"Tee","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"9","key":"10.1016\/j.amjsurg.2024.115820_bib11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/bjs.11249","article-title":"It is time for a biological definition of locally advanced pancreatic cancer","volume":"106","author":"Del Chiaro","year":"2019","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","article-title":"Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer","volume":"261","author":"Ferrone","year":"2015","journal-title":"Annals of surgery"},{"issue":"26","key":"10.1016\/j.amjsurg.2024.115820_bib13","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.3748\/wjg.v27.i26.4045","article-title":"Biomarkers in the diagnosis of pancreatic cancer: are we closer to finding the golden ticket?","volume":"27","author":"O'Neill","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.115820_bib14","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","article-title":"Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma","volume":"269","author":"Groot","year":"2019","journal-title":"Annals of surgery"},{"key":"10.1016\/j.amjsurg.2024.115820_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-94-017-7215-0_15","article-title":"CA 19-9: biochemical and clinical aspects","volume":"867","author":"Scara","year":"2015","journal-title":"Advances in experimental medicine and biology"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jamcollsurg.2018.03.031","article-title":"Utility of viscoelastic assays beyond coagulation: can preoperative thrombelastography indices predict tumor histology, nodal disease, and resectability in patients undergoing pancreatectomy?","volume":"227","author":"Moore","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.115820_bib17","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1097\/SLA.0000000000003976","article-title":"Thrombelastography as a prognostic tool in adenocarcinoma of the pancreas","volume":"272","author":"Schulick","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.amjsurg.2024.115820_bib18","series-title":"Ineligible Companies. Disclosure: David Sigmon Declares No Relevant Financial Relationships with Ineligible Companies. Disclosure: John Blebea Declares No Relevant Financial Relationships with Ineligible Companies","article-title":"Thromboelastography","author":"Shaydakov","year":"2024"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jbcr\/irad152","article-title":"Comparison of rapid-, kaolin-, and native-TEG parameters in burn patient cohorts with acute burn-induced coagulopathy and abnormal fibrinolytic function","volume":"45","author":"Keyloun","year":"2024","journal-title":"J\u00a0Burn Care Res"},{"issue":"12","key":"10.1016\/j.amjsurg.2024.115820_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1590\/S0100-879X2009001200015","article-title":"Normal range values for thromboelastography in healthy adult volunteers","volume":"42","author":"Scarpelini","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.amjsurg.2024.115820_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/468959","article-title":"Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review","volume":"2014","author":"Osayi","year":"2014","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.amjsurg.2024.115820_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00000658-199204000-00008","article-title":"Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma","volume":"215","author":"Tian","year":"1992","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.amjsurg.2024.115820_bib23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1245\/s10434-010-1397-1","article-title":"Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease","volume":"18","author":"Abdel-Misih","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jss.2006.10.007","article-title":"The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer","volume":"140","author":"Kang","year":"2007","journal-title":"J\u00a0Surg Res"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12957-016-1078-z","article-title":"Preoperative predictors for early recurrence of resectable pancreatic cancer","volume":"15","author":"Nishio","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"11","key":"10.1016\/j.amjsurg.2024.115820_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078977","article-title":"Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 patients from the pancreatic cancer cohort in a single institution","volume":"8","author":"Park","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0022-1759(85)90169-3","article-title":"Selection of monoclonal antibodies detecting serodiagnostic human tumor markers","volume":"80","author":"Herlyn","year":"1985","journal-title":"J\u00a0Immunol Methods"},{"issue":"Suppl 4","key":"10.1016\/j.amjsurg.2024.115820_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/annonc\/10.suppl_4.S145","article-title":"Role of tumour markers, cytogenetics","volume":"10","author":"Lamerz","year":"1999","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2024.115820_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9610(94)90050-7","article-title":"Characteristics of biliary tract complications during laparoscopic cholecystectomy: a multi-institutional study","volume":"167","author":"Woods","year":"1994","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115820_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/172460088800300204","article-title":"CA 19-9 assay in patients with extrahepatic cholestatic jaundice","volume":"3","author":"Barone","year":"1988","journal-title":"Int J Biol Markers"},{"issue":"23","key":"10.1016\/j.amjsurg.2024.115820_bib31","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.3748\/wjg.14.3750","article-title":"Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma","volume":"14","author":"Zhang","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.amjsurg.2024.115820_bib32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.surg.2014.02.001","article-title":"Borderline resectable pancreatic cancer: a consensus statement by the international study group of pancreatic surgery (ISGPS)","volume":"155","author":"Bockhorn","year":"2014","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.amjsurg.2024.115820_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11605-008-0696-3","article-title":"CA 19-9 velocity predicts disease-free survival and overall survival after pancreatectomy of curative intent","volume":"13","author":"Hernandez","year":"2009","journal-title":"J\u00a0Gastrointest Surg"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024003726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961024003726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T21:23:33Z","timestamp":1732224213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961024003726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"alternative-id":["S0002961024003726"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.115820","relation":{},"ISSN":["0002-9610"],"issn-type":[{"type":"print","value":"0002-9610"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampullary and pancreatic adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2024.115820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115820"}}